newsfilter
← Latest News
Business Wire·

Biocept Reports First Quarter 2022 Financial Results

Net revenues of $19.9 million up 12% over Q1 2021 CNSide™ assay volume up 219% over Q1 2021 and up 70% over Q4 2021 Expanded CNSide customer base with additional oncologists from six leading cancer centers Previews re-focused and rationa